Active Ingredient (In Each Tablet)
Meclizine HCl 25 mg
The following Structured Product Label (SPL) was submitted to the FDA by United Natural Foods, Inc. Dba Unfi for the product Motion Sickness Relief (NDC 41163-304). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Meclizine HCl 25 mg
Antiemetic
for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness
for children under 12 years of age unless directed by a doctor.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
corn starch, D&C yellow #10 aluminum lake, lactose, magnesium stearate, silica gel
1-877-932-7948
EQUALINE®
compare to Dramamine®
Less Drowsy Formula
active ingredient*
NDC 41163-304-02
motion sickness relief
meclizine HCl tablets 25 mg
(antiemetic)
less drowsy formula
helps prevent nausea & dizziness
due to motion sickness
for up to 24 hours
12 tablets
TAMPER EVIDENT:
USE ONLY IF THIS BLISTER IS INTACT
actual size
DOES NOT CONTAIN GLUTEN
*This product is not manufactured or distributed by
Prestige Brands, Inc., owner of the registered trademark
Dramamine® Less Drowsy Formula.
50844 REV0715B40302
DISTRIBUTED BY SUPERVALU INC.
EDEN PRAIRIE, MN 55344 USA
Contact us at 1-877-932-7948
SUPERVALU QUALITY
Guaranteed
We’re committed to your
satisfaction and guarantee
the quality of this product.
Contact us at 1-877-932-7948, or
www.supervalu-ourownbrands.com.
Please have package available.
* Please review the disclaimer below.